Multidisciplinary approach to improving treatment of community-acquired pneumonia

American Journal of Health-System Pharmacy

Volumn 59, Issue 4, 2002, Pages 364-368

  Cregin, Regina ^a   Segal Maurer, Sorona ^a   Weinbaum, Fredric ^a   Rahal, James ^a   Karbowitz, Stephen ^a   Sixsmith, Diane ^a   Cassata, Vito ^a   Danek, Margaret ^a   Battleman, David ^a   Callahan, Mark ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; ERYTHROMYCIN; OXYGEN; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; COMMUNICABLE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PNEUMONIA; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THORAX RADIOGRAPHY;

EID: 0037083417     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/59.4.364     Document Type: Article

References (35)

1. Severe community-acquired pneumonia - Etiology, prognosis, and treatment
2. Severe community-acquired pneumonia - Epidemiology and prognostic factors
3. Premature deaths, monthly mortality monthly physician and contacts - United States
4. Preventing mismanagement of community-acquired pneumonia at an urban public hospital - Implications for institution-specific practice guidelines
5. Diagnosis and management of pneumonia
6. Antibiotic choice and patient outcomes in community-acquired pneumonia
7. A nationwide survey of antibiotic prescribing patterns and clinical outcomes in patients with bacterial pneumonia
8. Community-acquired pneumonia in adults: Guidelines for management
9. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy
10. Compliance with national asthma management guidelines and specialty care: A health maintenance organization experience
11. Trends in antihypertensive drug use in the United States - Do the JNC V recommendations affect prescribing?
12. Why don't physicians follow clinical practice guidelines? A framework for improvement
13. Primary, care practice adherence to national cholesterol education program guidelines for patients with coronary, heart disease
14. Predictors of length of stay in community-acquired pneumonia. A multi-institutional study
15. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
16. Prevention of pneumococcal disease: Recommendation of the advisory committee on immunization practices
17. Hospitalization decision in patients with community-acquired pneumonia: A prospective cohort study
18. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients - An interventional trial
19. Improving antibiotic delivery time to pneumonia patients: Continuous quality improvement in action
20. Reducing lengths of stay for patients hospitalized with chest pain using medical practice guidelines and opinion leaders
21. Early transition to oral antibiotic therapy for community-acquired pneumonia: Duration of therapy, clinical outcomes, and cost analysis
22. A controlled trial of a critical pathway for treatment of community-acquired pneumonia
23. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia
24. Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia
25. Ambulatory patients with community-acquired pneumonia: The frequency of a typical agents and clinical course
26. Evaluation of a pneumonia practice guideline in an interventional trial
27. Change in physician knowledge and attitudes after implementation of a pneumonia practice guideline
28. A multihospital effort to reduce inpatient lengths of stay for pneumonia
29. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team
30. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team
31. New diagnostic approach to the patient with severe pneumonia
32. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia
33. Institution-specific patterns of infection and Gram's stain as guides for empiric treatment of patients hospitalized with typical community-acquired pneumonia
34. Clinical and economic outcomes of empiric parenteral antibiotic therapy for pneumonia: A retrospective study of 1,032 hospitalized patients